MediChem Enters Two-year Deal to Determine Protein Structures for Neurocrine Biosciences | GenomeWeb

NEW YORK, June 26 - MediChem Life Sciences has agreed to a two-year deal to crystallize and determine three-dimensional protein structures for Neurocrine Biosciences, the companies said Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.